spacer
home > ebr > winter 2003 > the progress of clinical trials
PUBLICATIONS
European Biopharmaceutical Review

The Progress of Clinical Trials

In the search to understand, prevent and treat disease, clinical trials involving healthy volunteers and patients play an essential role. How and why such trials are conducted needs to be understood by the public - as well as by key decision-makers - so that clinical research in the UK receives the focus and attention necessary for it to be successful. Nearly a quarter of the world's top 100 medicines were developed in the UK, making it a leading centre for clinical trials. But clinical studies are increasingly conducted around the world so that greater numbers of patients and different ethnicities can be included in a study.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Professor Trevor Jones, Director General at ABPI

Professor Trevor Jones is Director General of The Association of the British Pharmaceutical Industry, directing all activities relating to the UK pharmaceutical industry, including government relations, on behalf of 80 national and international pharmaceutical companies. From 1987 to 1994, Professor Jones was a main Board Director of Wellcome plc, the UK-based pharmaceuticals company, where he was responsible for R&D, including the development of Zovirax, AZT, Malarone, Lamictal and Tracrium. He was awarded the CBE in the 2003 New Year's Honours List.

spacer
Professor Trevor Jones
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm Expands Relationship With Novan On Formulation Science

MedPharm Ltd, a leader in topical and transdermal drug delivery, has expanded its relationship with the NASDAQ listed biopharmaceutical company Novan Inc. MedPharm has previously supported Novan by testing the companyís unique formulations using its proprietary in vitro models to optimise Novanís formulations and de-risk product development.
More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Inkís eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement